CCL2 and metabolic dysfunction-associated steatohepatitis: MCP-1, through multiple mechanisms, contributes to the pathogenesis of NASH, including hepatic lipid accumulation, insulin resistance, and coordinates leukocyte recruitment to the liver [15].